Point72 Asset Management L.P. lessened its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 86.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 101,375 shares of the company's stock after selling 644,449 shares during the period. Point72 Asset Management L.P. owned approximately 0.56% of Addus HomeCare worth $13,486,000 as of its most recent filing with the SEC.
Several other hedge funds also recently bought and sold shares of ADUS. Texas Permanent School Fund Corp grew its holdings in shares of Addus HomeCare by 0.6% in the 2nd quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company's stock valued at $1,636,000 after buying an additional 82 shares during the period. Arizona State Retirement System grew its stake in Addus HomeCare by 2.0% in the second quarter. Arizona State Retirement System now owns 4,543 shares of the company's stock valued at $527,000 after acquiring an additional 87 shares during the period. UMB Bank n.a. increased its holdings in shares of Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company's stock worth $26,000 after acquiring an additional 88 shares in the last quarter. Inspire Investing LLC raised its position in shares of Addus HomeCare by 3.3% during the third quarter. Inspire Investing LLC now owns 3,111 shares of the company's stock worth $414,000 after purchasing an additional 100 shares during the period. Finally, New York State Teachers Retirement System lifted its holdings in shares of Addus HomeCare by 1.2% during the 3rd quarter. New York State Teachers Retirement System now owns 8,510 shares of the company's stock valued at $1,132,000 after purchasing an additional 100 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other news, Director Esteban Lopez sold 500 shares of the company's stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the sale, the director now directly owns 3,366 shares of the company's stock, valued at approximately $429,165. This represents a 12.93 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the transaction, the chief executive officer now owns 141,897 shares of the company's stock, valued at $17,476,034.52. The trade was a 8.10 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on ADUS shares. StockNews.com cut Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Tuesday. Stephens increased their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 6th. KeyCorp assumed coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They issued an "overweight" rating and a $150.00 price objective on the stock. Oppenheimer increased their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an "outperform" rating in a report on Monday, September 23rd. Finally, Macquarie restated an "outperform" rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $131.63.
Check Out Our Latest Stock Analysis on ADUS
Addus HomeCare Trading Up 0.4 %
Shares of NASDAQ ADUS traded up $0.47 during mid-day trading on Friday, hitting $120.74. The company had a trading volume of 131,458 shares, compared to its average volume of 112,584. The firm has a 50-day simple moving average of $126.26 and a two-hundred day simple moving average of $123.97. The company has a market capitalization of $2.19 billion, a PE ratio of 27.63, a price-to-earnings-growth ratio of 2.16 and a beta of 1.01. Addus HomeCare Co. has a one year low of $85.94 and a one year high of $136.12.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same period last year, the company earned $1.03 earnings per share. The business's revenue was up 7.1% compared to the same quarter last year. Sell-side analysts expect that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.